HEPHL1
protein-codinghephaestin like 1
Gene summary
Enables ferroxidase activity. Involved in intracellular iron ion homeostasis. Predicted to be located in membrane. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~92.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0009871
Submitter: ClinGen
*HEPHL1* was first reported in relation to autosomal dominant iron overload in 2015 (McDonald CM et al., PMID: PMID: 26151776) the p.Asp136Val variant mentioned in this study is found in 101 alleles including 1 homozygous in gnomAD V4 making it’s role unclear in the proband described. Biallelic *HEPHL1 *variants were later associated with a phenotype of pilli torti and developmental delay (Sharma P et al., PMID: 31125343). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanism using the evidence provided by these papers. Therefore, the following disease entities have been lumped into one disease entities pili torti-developmental delay-neurological abnormalities syndrome. Two variants (one missense and one in-frame del, that have been reported in one probands in one publications (Sharma P et al., PMID: 31125343) are included in this curation. The mechanism of pathogenicity appears to be loss of function as both published variants reported resulted in non-detectable conversion of Fe (II) to Fe (III) indicating that that both mutants were catalytically inactive in the assay (Sharma P et al., PMID: 31125343). This gene-disease relationship is also supported by mouse models where Hephl1 knockout mouse model exhibited short, curled whiskers that was not found in Heterozygous mice (Zp+/-) models (Sharma P et al., PMID: 31125343). No additional neurological phenotypes were tested in these animal models according to the publication. In summary, there is limited evidence supporting the relationship between HEPHL1 and autosomal recessive pili torti-developmental delay-neurological abnormalities syndrome. This classification was approved by the ClinGen IEM GCEP on the meeting date February 14 (SOP Version 11).
Inheritance Pattern: AR
Disease ID:MONDO:0009871
Submitter: PanelApp Australia
Inheritance Pattern: Unknown
Disease ID:MONDO:0009871
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Dermatologic; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to HEPHL1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001098672.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 15 | 3 | 18 | |||
| missense | 184 | 12 | 5 | 201 | ||
| nonsense | 3 | 2 | 5 | |||
| start loss | 0 | |||||
| frameshift | 2 | 2 | ||||
| splice donor/acceptor (+/-2bp) | 1 | 3 | 4 | |||
| Total | 0 | 6 | 189 | 27 | 8 | 230 |
Highest pathogenic variant AF is 0.00008738041
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001092142.1 | 20 | MANE Select | |
| Ensembl | ENSP00000313699.9 | 20 | MANE Select |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Iron metabolism in placenta
Biological Process
- copper ion transport
- iron ion transport
- iron ion homeostasis
- oxidation-reduction process
Molecular Function
- ferroxidase activity
- copper ion binding
- oxidoreductase activity
Cellular Component
- plasma membrane
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000315765
- Coding exons
- 20
- Length
- 92391
- Individuals with no LoFs
- 124272
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 378
- Defined
- 124651
- p
- 0.00152
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.184 | 622 | 635 | 0.979 | 0.0000326 | 7663 |
| Missense (PolyPhen) | 247 | 255.14 | 0.96809 | 3158 | ||
| Synonymous | -0.606 | 248 | 236 | 1.05 | 0.0000131 | 2180 |
| Loss of Function | 0.409 | 54 | 57.3 | 0.942 | 0.00000334 | 646 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0012 | 0.0012 | notable |
| Latino/Admixed American | 0.0014 | 0.0014 | notable |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.0043 | 0.0043 | notable |
| Finnish | 0.00098 | 0.00098 | rare |
| European (Non-Finnish) | 0.0012 | 0.0012 | notable |
| South Asian | 0.0021 | 0.0021 | notable |
| Other | 0.0025 | 0.0025 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May function as a ferroxidase and may be involved in copper transport and homeostasis. {ECO:0000250}.;
Intolerance Scores
- LoFtool
- 0.207
- RVIS EVS
- -0.28
- RVIS percentile EVS
- 33.59
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.269
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |